Sodium hydrogen exchangers contribute to arenavirus cell entry

Journal of Virology

Volumn 88, Issue 1, 2014, Pages 643-654

  Iwasaki, Masaharu ^a   Ngo, Nhi ^a   de la Torre, Juan C ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (N ISOBUTYL N METHYL)AMILORIDE; ACTIN; P21 ACTIVATED KINASE 1; SODIUM PROTON EXCHANGE PROTEIN; ZONIPORIDE;

ANTIVIRAL ACTIVITY; ARENAVIRUS; ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DRUG TARGETING; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN VERSUS ANIMAL COMPARISON; JUNIN VIRUS; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; RNA REPLICATION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS RELEASE; VIRUS VIRULENCE;

ANIMALS; ARENAVIRUS; BLOTTING, WESTERN; CELL LINE; HUMANS; MEMBRANE FUSION; SODIUM-HYDROGEN ANTIPORTER;

EID: 84890861268     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02110-13     Document Type: Article

References (88)

1. Buchmeier MJ, Peters CJ, de la Torre JC. 2007. Arenaviridae: the viruses and their replication, p 1791-1851. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Enria DA, Briggiler AM, Sanchez Z. 2008. Treatment of Argentine hemorrhagic fever. Antiviral Res. 78:132-139. http://dx.doi.org/10.1016/j .antiviral.2007.10.010.
3. Geisbert TW, Jahrling PB. 2004. Exotic emerging viral diseases: progress and challenges. Nat. Med. 10:S110-S121. http://dx.doi.org/10.1038 /nm1142.
4. Khan SH, Goba A, Chu M, Roth C, Healing T, Marx A, Fair J, Guttieri MC, Ferro P, Imes T, Monagin C, Garry RF, Bausch DG, Mano River Union Lassa Fever Network. 2008. New opportunities for field researchon the pathogenesis and treatment of Lassa fever. Antiviral Res. 78:103- 115. http://dx.doi.org/10.1016/j.antiviral.2007.11.003.
5. McCormick JB, Fisher-Hoch SP. 2002. Lassa fever. Curr. Top. Microbiol. Immunol. 262:75-109.
6. Peters CJ. 2002. Human infection with arenaviruses in the Americans. Curr. Top. Microbiol. Immunol. 262:65-74. 7. Weissenbacher MC, Laguens RP, Coto CE. 1987. Argentine hemorrhagic fever. Curr. Top. Microbiol. Immunol. 134:79-116. http://dx.doi .org/10.1007/978-3-642-71726-0_4.
7. Weissenbacher MC, Laguens RP, Coto CE. 1987. Argentine hemorrhagic fever. Curr. Top. Microbiol. Immunol. 134:79-116. http://dx.doi.org/10.1007/978-3-642-71726-0_4
8. Barton LL, Mets MB. 2001. Congenital lymphocytic choriomeningitis virus infection: decade of rediscovery. Clin. Infect. Dis. 33:370-374. http: //dx.doi.org/10.1086/321897.
9. Barton LL, Mets MB. 1999. Lymphocytic choriomeningitis virus: pediatric pathogen and fetal teratogen. Pediatr. Infect. Dis. J. 18:540-541. http: //dx.doi.org/10.1097/00006454-199906000-00013.
10. Barton LL, Mets MB, Beauchamp CL. 2002. Lymphocytic choriomeningitis virus: emerging fetal teratogen. Am. J. Obstet. Gynecol. 187:1715- 1716. http://dx.doi.org/10.1067/mob.2002.126297.
11. Jahrling PB, Peters CJ. 1992. Lymphocytic choriomeningitis virus. A neglected pathogen of man. Arch. Pathol. Lab. Med. 116:486-488.
12. Mets MB, Barton LL, Khan AS, Ksiazek TG. 2000. Lymphocytic choriomeningitis virus: an underdiagnosed cause of congenital chorioretinitis. Am. J. Ophthalmol. 130:209-215. http://dx.doi.org/10.1016/S0002 -9394(00)00570-5.
13. Fischer SA, Graham MB, Kuehnert MJ, Kotton CN, Srinivasan A, Marty FM, Comer JA, Guarner J, Paddock CD, DeMeo DL, Shieh WJ, Erickson BR, Bandy U, DeMaria A, Jr, Davis JP, Delmonico FL, Pavlin B, Likos A, Vincent MJ, Sealy TK, Goldsmith CS, Jernigan DB, Rollin PE, Packard MM, Patel M, Rowland C, Helfand RF, Nichol ST, Fishman JA, Ksiazek T, Zaki SR, LCMV in Transplant Recipients Investigation Team. 2006. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N. Engl. J. Med. 354:2235-2249. http://dx.doi .org/10.1056/NEJMoa053240.
14. Peters CJ. 2006. Lymphocytic choriomeningitis virus-an old enemy up to new tricks. N. Engl. J. Med. 354:2208-2211. http://dx.doi.org/10.1056 /NEJMp068021.
15. Damonte EB, Coto CE. 2002. Treatment of arenavirus infections: from basic studies to the challenge of antiviral therapy. Adv. Virus Res. 58:125- 155. http://dx.doi.org/10.1016/S0065-3527(02)58004-0.
16. Moreno H, Gallego I, Sevilla N, de la Torre JC, Domingo E, Martin V. 2011. Ribavirin can be mutagenic for arenaviruses. J. Virol. 85:7246-7255. http://dx.doi.org/10.1128/JVI.00614-11.
17. Parker WB. 2005. Metabolism and antiviral activity of ribavirin. Virus Res. 107:165-171. http://dx.doi.org/10.1016/j.virusres.2004.11.006.
18. Cao W, Henry MD, Borrow P, Yamada H, Elder JH, Ravkov EV, Nichol ST, Compans RW, Campbell KP, Oldstone MB. 1998. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282:2079-2081. http://dx.doi.org/10.1126 /science.282.5396.2079.
19. Radoshitzky SR, Abraham J, Spiropoulou CF, Kuhn JH, Nguyen D, Li W, Nagel J, Schmidt PJ, Nunberg JH, Andrews NC, Farzan M, Choe H. 2007. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446:92-96. http://dx.doi.org/10.1038 /nature05539.
20. Salvato MS. 1993. Molecular biology of the prototype arenavirus, lymphocytic choriomeningitis virus. Plenum Press, New York, NY.
21. Salvato MS, Schweighofer KJ, Burns J, Shimomaye EM. 1992. Biochemical and immunological evidence that the 11 kDa zinc-binding protein of lymphocytic choriomeningitis virus is a structural component of the virus. Virus Res. 22:185-198. http://dx.doi.org/10.1016/0168-1702(92)90050-J.
22. Panda D, Das A, Dinh PX, Subramaniam S, Nayak D, Barrows NJ, Pearson JL, Thompson J, Kelly DL, Ladunga I, Pattnaik AK. 2011. RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses. Proc. Natl. Acad. Sci. U. S. A. 108:19036-19041. http://dx.doi.org/10.1073/pnas.1113643108.
23. Dowrick P, Kenworthy P, McCann B, Warn R. 1993. Circular ruffle formation and closure lead to macropinocytosis in hepatocyte growth factor/scatter factor-treated cells. Eur. J. Cell Biol. 61:44-53.
24. West MA, Bretscher MS, Watts C. 1989. Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells. J. Cell Biol. 109:2731-2739. http://dx.doi.org/10.1083/jcb.109.6.2731.
25. Masereel B, Pochet L, Laeckmann D. 2003. An overview of inhibitors of Na(+)/H(+) exchanger. Eur. J. Med. Chem. 38:547-554. http://dx.doi .org/10.1016/S0223-5234(03)00100-4.
26. Rojek JM, Kunz S. 2008. Cell entry by human pathogenic arenaviruses. Cell. Microbiol. 10:828-835. http://dx.doi.org/10.1111/j.1462-5822.2007 .01113.x.
27. Borrow P, Oldstone MB. 1994. Mechanism of lymphocytic choriomeningitis virus entry into cells. Virology 198:1-9. http://dx.doi.org/10.1006 /viro.1994.1001.
28. Quirin K, Eschli B, Scheu I, Poort L, Kartenbeck J, Helenius A. 2008. Lymphocytic choriomeningitis virus uses a novel endocytic pathway for infectious entry via late endosomes. Virology 378:21-33. http://dx.doi.org /10.1016/j.virol.2008.04.046.
29. Rojek JM, Perez M, Kunz S. 2008. Cellular entry of lymphocytic choriomeningitis virus. J. Virol. 82:1505-1517. http://dx.doi.org/10.1128/JVI .01331-07.
30. Rojek JM, Sanchez AB, Nguyen NT, de la Torre JC, Kunz S. 2008. Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. J. Virol. 82:7677-7687. http://dx.doi.org/10 .1128/JVI.00560-08.
31. Shah WA, Peng H, Carbonetto S. 2006. Role of non-raft cholesterol in lymphocytic choriomeningitis virus infection via alpha-dystroglycan. J. Gen. Virol. 87:673-678. http://dx.doi.org/10.1099/vir.0.81444-0.
32. Vela EM, Zhang L, Colpitts TM, Davey RA, Aronson JF. 2007. Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin- mediated endocytic mechanism. Virology 369:1-11. http://dx.doi.org /10.1016/j.virol.2007.07.014.
33. Martinez MG, Cordo SM, Candurra NA. 2007. Characterization of Junin arenavirus cell entry. J. Gen. Virol. 88:1776-1784. http://dx.doi.org/10 .1099/vir.0.82808-0.
34. Guzman-Perez A, Wester RT, Allen MC, Brown JA, Buchholz AR, Cook ER, Day WW, Hamanaka ES, Kennedy SP, Knight DR, Kowalczyk PJ, Marala RB, Mularski CJ, Novomisle WA, Ruggeri RB, Tracey WR, Hill RJ. 2001. Discovery of zoniporide: a potent and selective sodiumhydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility. Bioorg. Med. Chem. Lett. 11:803-807. http://dx.doi.org/10.1016 /S0960-894X(01)00059-2.
35. Fleisher LA, Newman MF, St. Aubin LB, Cropp AB, Billing CB, Bonney S, Mackey WC, Poldermans D, Corbalan R, Pereira AH, Coriat P, Perioperative Myocardial Ischemic Injury Investigators. 2005. Efficacy of zoniporide, an Na/H exchange ion inhibitor, for reducing perioperative cardiovascular events in vascular surgery patients. J. Cardiothorac. Vasc. Anesth. 19:570-576. http://dx.doi.org/10.1053/j.jvca.2005.06.012.
36. Lee KJ, Novella IS, Teng MN, Oldstone MB, de La Torre JC. 2000. NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J. Virol. 74:3470-3477. http://dx.doi.org/10.1128/JVI.74.8.3470 -3477.2000.
37. Lee KJ, Perez M, Pinschewer DD, de la Torre JC. 2002. Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles. J. Virol. 76:6393- 6397. http://dx.doi.org/10.1128/JVI.76.12.6393-6397.2002.
38. Urata S, Yasuda J, de la Torre JC. 2009. The Z protein of the New World arenavirus Tacaribe virus has bona fide budding activity that does not depend on known late domain motifs. J. Virol. 83:12651-12655. http://dx .doi.org/10.1128/JVI.01012-09.
39. Nonnenmacher M, Weber T. 2011. Adeno-associated virus 2 infection requires endocytosis through the CLIC/GEEC pathway. Cell Host Microbe 10:563-576. http://dx.doi.org/10.1016/j.chom.2011.10.014.
40. Sells MA, Knaus UG, Bagrodia S, Ambrose DM, Bokoch GM, Chernoff J. 1997. Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Curr. Biol. 7:202-210. http://dx.doi.org/10.1016 /S0960-9822(97)70091-5.
41. Emonet SF, Garidou L, McGavern DB, de la Torre JC. 2009. Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest. Proc. Natl. Acad. Sci. U. S. A. 106:3473-3478. http://dx.doi.org/10 .1073/pnas.0900088106.
42. Pinschewer DD, Perez M, Sanchez AB, de la Torre JC. 2003. Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 100:7895-7900. http://dx .doi.org/10.1073/pnas.1332709100.
43. Sánchez AB, de la Torre JC. 2006. Rescue of the prototypic arenavirusLCMVentirely from plasmid. Virology 350:370-380. http://dx.doi.org/10 .1016/j.virol.2006.01.012.
44. Battegay M. 1993. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 well plates. ALTEX 10:6-14.
45. Vazquez-Calvo A, Martin-Acebes MA, Saiz JC, Ngo N, Sobrino F, de la Torre JC. 2013. Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid. Antiviral Res.. http://dx.doi.org/10.1016/j .antiviral.2013.05.012.
46. Urata S, Ngo N, de la Torre JC. 2012. The PI3K/Akt pathway contributes to arenavirus budding. J. Virol. 86:4578-4585. http://dx.doi.org/10.1128 /JVI.06604-11.
47. Nanbo A, Imai M, Watanabe S, Noda T, Takahashi K, Neumann G, Halfmann P, Kawaoka Y. 2010. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog. 6:e1001121. http://dx.doi.org/10.1371/journal.ppat.1001121.
48. Smelt SC, Borrow P, Kunz S, Cao W, Tishon A, Lewicki H, Campbell KP, Oldstone MB. 2001. Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics. J. Virol. 75:448-457. http://dx.doi.org/10.1128/JVI.75.1.448-457.2001.
49. Koivusalo M, Welch C, Hayashi H, Scott CC, Kim M, Alexander T, Touret N, Hahn KM, Grinstein S. 2010. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J. Cell Biol. 188:547-563. http://dx.doi.org/10.1083/jcb .200908086.
50. Kumari S, Mayor S. 2008. ARF1 is directly involved in dynaminindependent endocytosis. Nat. Cell Biol. 10:30-41. http://dx.doi.org/10 .1038/ncb1666.
51. Lundmark R, Doherty GJ, Howes MT, Cortese K, Vallis Y, Parton RG, McMahon HT. 2008. The GTPase-activating protein GRAF1 regulates the CLIC/GEEC endocytic pathway. Curr. Biol. 18:1802-1808. http://dx.doi .org/10.1016/j.cub.2008.10.044.
52. Sabharanjak S, Sharma P, Parton RG, Mayor S. 2002. GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42- regulated, clathrin-independent pinocytic pathway. Dev. Cell 2:411-423. http://dx.doi.org/10.1016/S1534-5807(02)00145-4.
53. Doherty GJ, Lundmark R. 2009. GRAF1-dependent endocytosis. Biochem. Soc. Trans. 37:1061-1065. http://dx.doi.org/10.1042 /BST0371061.
54. Mercer J, Schelhaas M, Helenius A. 2010. Virus entry by endocytosis. Annu. Rev. Biochem. 79:803-833. http://dx.doi.org/10.1146/annurev -biochem-060208-104626.
55. Hoffmann PR, deCathelineau AM, Ogden CA, Leverrier Y, Bratton DL, Daleke DL, Ridley AJ, Fadok VA, Henson PM. 2001. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J. Cell Biol. 155:649-659. http://dx.doi.org/10 .1083/jcb.200108080.
56. Jemielity S, Wang JJ, Chan YK, Ahmed AA, Li W, Monahan S, Bu X, Farzan M, Freeman GJ, Umetsu DT, Dekruyff RH, Choe H. 2013. TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine. PLoS Pathog. 9:e1003232. http://dx.doi.org/10.1371/journal.ppat.1003232.
57. Meertens L, Carnec X, Lecoin MP, Ramdasi R, Guivel-Benhassine F, Lew E, Lemke G, Schwartz O, Amara A. 2012. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe 12:544-557. http://dx.doi.org/10.1016/j.chom.2012.08.009 .
58. Moller-Tank S, Kondratowicz AS, Davey RA, Rennert PD, Maury W. 2013. Role of the phosphatidylserine receptor TIM-1 in enveloped virus entry. J. Virol. 87:8327-8341. http://dx.doi.org/10.1128/JVI.01025-13.
59. Morizono K, Xie Y, Olafsen T, Lee B, Dasgupta A, Wu AM, Chen IS. 2011. The soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entry. Cell Host Microbe 9:286-298. http://dx.doi.org/10.1016/j.chom.2011.03 .012.
60. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ. 2008. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319:921-926. http://dx.doi.org/10.1126/science.1152725.
61. Hao L, Sakurai A, Watanabe T, Sorensen E, Nidom CA, Newton MA, Ahlquist P, Kawaoka Y. 2008. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 454:890-893. http://dx.doi.org/10.1038/nature07151.
62. Krishnan MN, Ng A, Sukumaran B, Gilfoy FD, Uchil PD, Sultana H, Brass AL, Adametz R, Tsui M, Qian F, Montgomery RR, Lev S, Mason PW, Koski RA, Elledge SJ, Xavier RJ, Agaisse H, Fikrig E. 2008. RNA interference screen for human genes associated with West Nile virus infection. Nature 455:242-245. http://dx.doi.org/10.1038/nature07207.
63. Castilla V, Mersich SE, Candurra NA, Damonte EB. 1994. The entry of Junin virus into Vero cells. Arch. Virol. 136:363-374. http://dx.doi.org/10 .1007/BF01321064.
64. Kunz S, Rojek JM, Perez M, Spiropoulou CF, Oldstone MB. 2005. Characterization of the interaction of lassa fever virus with its cellular receptor alpha-dystroglycan. J. Virol. 79:5979-5987. http://dx.doi.org/10 .1128/JVI.79.10.5979-5987.2005.
65. Kunz S, Sevilla N, McGavern DB, Campbell KP, Oldstone MB. 2001. Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan. J. Cell Biol. 155:301-310. http://dx.doi.org/10.1083 /jcb.200104103.
66. Kunz S, Sevilla N, Rojek JM, Oldstone MB. 2004. Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus. Virology 325:432-445. http://dx.doi.org /10.1016/j.virol.2004.05.009.
67. Reignier T, Oldenburg J, Noble B, Lamb E, Romanowski V, Buchmeier MJ, Cannon PM. 2006. Receptor use by pathogenic arenaviruses. Virology 353:111-120. http://dx.doi.org/10.1016/j.virol.2006.05.018.
68. Spiropoulou CF, Kunz S, Rollin PE, Campbell KP, Oldstone MB. 2002. New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor. J. Virol. 76:5140-5146. http://dx .doi.org/10.1128/JVI.76.10.5140-5146.2002.
69. Forgac M. 2007. Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat. Rev. Mol. Cell Biol. 8:917-929. http://dx.doi .org/10.1038/nrm2272.
70. Kirkham M, Fujita A, Chadda R, Nixon SJ, Kurzchalia TV, Sharma DK, Pagano RE, Hancock JF, Mayor S, Parton RG. 2005. Ultrastructural identification of uncoated caveolin-independent early endocytic vehicles. J. Cell Biol. 168:465-476. http://dx.doi.org/10.1083/jcb.200407078.
71. Liu NQ, Lossinsky AS, Popik W, Li X, Gujuluva C, Kriederman B, Roberts J, Pushkarsky T, Bukrinsky M, Witte M, Weinand M, Fiala M. 2002. Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogenactivated protein kinase signaling pathway. J. Virol. 76:6689-6700. http: //dx.doi.org/10.1128/JVI.76.13.6689-6700.2002.
72. Maréchal V, Prevost MC, Petit C, Perret E, Heard JM, Schwartz O. 2001. Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J. Virol. 75:11166-11177. http://dx.doi .org/10.1128/JVI.75.22.11166-11177.2001.
73. de Vries E, Tscherne DM, Wienholts MJ, Cobos-Jimenez V, Scholte F, Garcia-Sastre A, Rottier PJ, de Haan CA. 2011. Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog. 7:e1001329. http://dx.doi.org/10.1371 /journal.ppat.1001329.
74. Rossman JS, Leser GP, Lamb RA. 2012. Filamentous influenza virus enters cells via macropinocytosis. J. Virol. 86:10950-10960. http://dx.doi .org/10.1128/JVI.05992-11.
75. Saeed MF, Kolokoltsov AA, Albrecht T, Davey RA. 2010. Cellular entry of Ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog. 6:e1001110. http://dx.doi.org/10.1371/journal.ppat.1001110.
76. Coyne CB, Shen L, Turner JR, Bergelson JM. 2007. Coxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5. Cell Host Microbe 2:181-192. http://dx.doi.org/10.1016 /j.chom.2007.07.003.
77. Karjalainen M, Kakkonen E, Upla P, Paloranta H, Kankaanpaa P, Liberali P, Renkema GH, Hyypia T, Heino J, Marjomaki V. 2008. A Raft-derived, Pak1-regulated entry participates in alpha2beta1 integrindependent sorting to caveosomes. Mol. Biol. Cell 19:2857-2869. http://dx .doi.org/10.1091/mbc.E07-10-1094.
78. Liberali P, Kakkonen E, Turacchio G, Valente C, Spaar A, Perinetti G, Bockmann RA, Corda D, Colanzi A, Marjomaki V, Luini A. 2008. The closure of Pak1-dependent macropinosomes requires the phosphorylation of CtBP1/BARS. EMBO J. 27:970-981. http://dx.doi.org/10.1038 /emboj.2008.59.
79. Mercer J, Helenius A. 2008. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320:531-535. http://dx.doi .org/10.1126/science.1155164.
80. Nicola AV, Hou J, Major EO, Straus SE. 2005. Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pHdependent endocytic pathway. J. Virol. 79:7609-7616. http://dx.doi.org /10.1128/JVI.79.12.7609-7616.2005.
81. Nicola AV, McEvoy AM, Straus SE. 2003. Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J. Virol. 77:5324-5332. http://dx.doi.org/10.1128/JVI.77.9.5324-5332.2003.
82. Meier O, Boucke K, Hammer SV, Keller S, Stidwill RP, Hemmi S, Greber UF. 2002. Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J. Cell Biol. 158:1119- 1131. http://dx.doi.org/10.1083/jcb.200112067.
83. Pasqual G, Rojek JM, Masin M, Chatton JY, Kunz S. 2011. Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport. PLoS Pathog. 7:e1002232. http://dx.doi.org/10.1371/journal.ppat.1002232.
84. Krzyzaniak MA, Zumstein MT, Gerez JA, Picotti P, Helenius A. 2013. Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein. PLoS Pathog. 9:e1003309. http://dx.doi.org/10.1371/journal.ppat.1003309.
85. Kolokoltsov AA, Adhikary S, Garver J, Johnson L, Davey RA, Vela EM. 2012. Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin. Arch. Virol. 157:121-127. http://dx.doi.org/10.1007/s00705-011-1115-8.
86. Vela EM, Bowick GC, Herzog NK, Aronson JF. 2008. Genistein treatment of cells inhibits arenavirus infection. Antiviral Res. 77:153-156. http: //dx.doi.org/10.1016/j.antiviral.2007.09.005.
87. Avkiran M, Marber MS. 2002. Na(+)/H(+) exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J. Am. Coll. Cardiol. 39:747-753. http://dx.doi.org/10.1016/S0735-1097(02)01693-5.
88. Orlowski J, Grinstein S. 2004. Diversity of the mammalian sodium/ proton exchanger SLC9 gene family. Pflugers Arch. 447:549-565. http: //dx.doi.org/10.1007/s00424-003-1110-3.